NASDAQ:ADPT

Adaptive Biotechnologies (ADPT) stock swings after earnings as MRD guidance, insider sale draw scrutiny

Shares of Adaptive Biotechnologies dropped 5.2% to $15.61 Friday afternoon, giving up early gains as enthusiasm over the company’s quarterly results and 2026 outlook faded. The stock’s range for the day ran from $17.69 down to $15.08.

6 February 2026

Earnings Reports·NASDAQ:ADPT·Stock Market

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Shares of Adaptive Biotechnologies rose 6.5% to $17.15 on Wednesday, after trading between $16.24 and $17.33, giving the company a market value of about $2.0 billion. The stock has traded between $4.32 and $21.89 over the past 52 weeks.

7 January 2026

Biotechnology·NASDAQ:ADPT·Stock Market

Pfizer Stock After Hours (PFE) on Dec. 15, 2025: What Moved Shares Today—and What to Watch Before Tuesday’s Open

Pfizer Inc. ended Monday’s session on a strong note, then traded slightly lower after the closing bell as investors shifted their attention to the next major catalyst: Pfizer’s scheduled analyst call Tuesday morning, where management is expected to outline full-year 2026 financial guidance. Yahoo Finance+2Pfizer+2

16 December 2025

NASDAQ:ADPT·NYSE:PFE·Pfizer·Stock Market

Biggest Stock Losers Today (December 5, 2025): Parsons, Adaptive Biotechnologies, SentinelOne, SoFi and More Slide Despite Calm Markets

U.S. stocks ended Friday modestly higher, but under the surface December 5, 2025 was a rough day for a cluster of high‑beta tech, Brazilian financials, streaming, and crypto‑linked names.

6 December 2025

NASDAQ:ADPT·NASDAQ:INTR·NASDAQ:NNNN·NASDAQ:PSKY·NASDAQ:XP·NYSE:AGX·NYSE:CSAN·NYSE:DOCS·NYSE:PSN·NYSE:S·Stock Market

Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Sources: Key news and expert quotes were gathered from Fierce Biotech fiercebiotech.com fiercebiotech.com, Fierce Pharma fiercepharma.com fiercepharma.com, Fierce Healthcare fiercehealthcare.com fiercehealthcare.com, STAT News statnews.com statnews.com, the Florida Phoenix floridaphoenix.com floridaphoenix.com, CIDRAP cidrap.umn.edu cidrap.umn.edu, and other authoritative sources as cited above. Each development is linked to its original reporting for further reading. The roundup covers events and announcements from August 18–19, 2025, providing a comprehensive digest of the latest in biotech, pharma, medical, and health news.

19 August 2025

Biotechnology·NASDAQ:ADAP·NASDAQ:ADPT·NYSE:RHHBY·Pharmaceuticals

NASDAQ:ADPT 19 August 2025 - 6 February 2026

Adaptive Biotechnologies (ADPT) stock swings after earnings as MRD guidance, insider sale draw scrutiny

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Pfizer Stock After Hours (PFE) on Dec. 15, 2025: What Moved Shares Today—and What to Watch Before Tuesday’s Open

Biggest Stock Losers Today (December 5, 2025): Parsons, Adaptive Biotechnologies, SentinelOne, SoFi and More Slide Despite Calm Markets

Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

TechStock² Updates

Strategy (NASDAQ:MSTR) Moves Back Above $100 as Bitcoin-Per-Share Edge Shrinks

BitMine (NYSE:BMNR) rises 9%, but share buyback remains minor against Ethereum holdings

Navy allocates $9.8 million seabed contract, bringing Integer-USM close to contract maximum

Roblox (NYSE:RBLX) Shares Recover While 6% Bookings Decline per Payer Challenges Strategy Shift

SpaceX (NASDAQ:SPCX) Shares Buoyed by AI Investments Despite Moon Impact Crater

Top Stock Picks

Constellation Energy

AerCap

Walt Disney

AIG

Cheniere Energy

Live updates

Investment Disclaimer